AAAAAA

   
Results: 1-8 |
Results: 8
Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease
Authors: Sarna, J Miranda, SRP Schuchman, EH Hawkes, R
Citation: J. Sarna et al., Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease, EUR J NEURO, 13(10), 2001, pp. 1873-1880
Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease
Authors: Miranda, SRP Erlich, S Friedrich, VL Gatt, S Schuchman, EH
Citation: Srp. Miranda et al., Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease, GENE THER, 7(20), 2000, pp. 1768-1776
Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function
Authors: Marathe, S Miranda, SRP Devlin, C Johns, A Kuriakose, G Williams, KJ Schuchman, EH Tabas, I
Citation: S. Marathe et al., Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function, HUM MOL GEN, 9(13), 2000, pp. 1967-1976
Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology
Authors: Miranda, SRP He, XX Simonaro, CM Gatt, S Dagan, A Desnick, RJ Schuchman, EH
Citation: Srp. Miranda et al., Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology, FASEB J, 14(13), 2000, pp. 1988-1995
Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells based on acid sphingomyelinase expression
Authors: Schuchman, EH Erlich, S Miranda, SRP Dinur, T Dagan, A Gatt, S
Citation: Eh. Schuchman et al., Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells based on acid sphingomyelinase expression, METH ENZYM, 312, 2000, pp. 330-338
Characterization of human acid sphingomyelinase purified from the media ofoverexpressing Chinese hamster ovary cells
Authors: He, XX Miranda, SRP Xiong, XL Dagan, A Gatt, S Schuchman, EH
Citation: Xx. He et al., Characterization of human acid sphingomyelinase purified from the media ofoverexpressing Chinese hamster ovary cells, BBA-PROT ST, 1432(2), 1999, pp. 251-264
Detection of cytomegalovirus infections by PCR in renal transplant patients
Authors: Costa, SCB Miranda, SRP Alves, G Rossi, CL Figueiredo, LTM Costa, FF
Citation: Scb. Costa et al., Detection of cytomegalovirus infections by PCR in renal transplant patients, BRAZ J MED, 32(8), 1999, pp. 953-959
Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: Implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures
Authors: Erlich, S Miranda, SRP Visser, JWM Dagan, A Gatt, S Schuchman, EH
Citation: S. Erlich et al., Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: Implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures, BLOOD, 93(1), 1999, pp. 80-86
Risultati: 1-8 |